药品集采效果评价指标体系和模型构建  

Construction of Effect Evaluation Index System and Model for Centralized Drug Procurement

作　　者：李婵 锁驰 徐焦 周明旺 赵雪娟 李璠 

机构地区：[1]昆明医科大学药学院暨云南省天然药物药理重点实验室,昆明650500 [2]云南省药物政策研究中心,昆明650500 [3]中国科学院大学温州研究院,温州325001

出　　处：《中国医疗保险》2022年第10期27-31,共5页China Health Insurance

摘　　要：目的:构建一套完整的药品集中采购政策效果评价指标体系和模型。方法:采用文献研究、专家咨询和德尔菲法等方式建立药品集中采购政策实施效果评价指标体系,运用模糊层次分析法和对比分析法构建评价模型,并以云南省相关数据为例开展实证研究。结果:评价指标体系包含4个一级指标、11个二级指标和30个三级指标。其中一级指标中药品可及性和医药影响方面权重系数相对较高。结论:本指标体系和评价模型遵循全面性、系统性、科学性、可操作性和主成分原则,可为其他地区开展药品集中采购政策效果评价提供参考。Objective: The paper is to establish a complete evaluation index system and model for the effect of centralized drug procurement policy. Methods: Literature research, expert consultation and Delphi method were used to establish the evaluation index system of the implementation effect of centralized drug procurement policy, and fuzzy analytic hierarchy process(AHP) and comparative analysis were used to establish the evaluation model, taking data of Yunnan Province as an example to conduct empirical research. Results: The evaluation index system contains 4 first-level indicators, 11 second-level indicators and 30 tertiary indicators. Among the first-level indicators, drug accessibility and drug effects weight coefficient is relatively high. Conclusion: The index system and evaluation model follow the principle of comprehensiveness, systematicness, scientificity, operability and principal component,which can provide guidance for evaluating the effect of centralized drug procurement policy in other regions.

关 键 词：药品集中采购 政策效果评价 模糊层次分析法 对比分析法 指标体系 

分 类 号：F840.684[经济管理—保险] C913.7[社会学]